KromaTiD Inc.

KromaTiD develops and markets proprietary products and services for studying the root causes of genetic diseases including cancers and developmental disorders.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Fort Collins, CO, USA
  • Currency USD
  • Founded December 2007
  • Employees 5
  • Website kromatid.com

Company Summary

KromaTiD, Inc. is commercializing a breakthrough genomic technology that will advance precision medicine. KromaTiD has moved past proof of concept and is selling proprietary products and services that are being applied to further the understanding of the genetic basis of cancers and developmental disorders.

Team

  • Board Chairman

    Former Divisional Vice President at Abbott and currently holds a number of positions. President and CEO, Vidasym, Inc., Founder and CSO, VetDC, Inc., and Vice President, CSU Ventures.

  • President & COO

    20 years of pharmaceutical and biotechnology industry experience in the cytogenetic markets. Former COO at Evia Medical and GM of Proligo LLC. Former lead project engineer at NeXstar Pharmaceuticals and Hoffmann-La Roche. Ph.D. in Chemical Engineering from NC State.

  • 20 years hands on experience commercializing technology and building successful ventures in life sciences. Former CEO of Gentel Biosciences and VP of Sales and Marketing PanVera Corporation. Former research scientist at Pfizer and Abbott. Holds MS and BS degrees from UW-Madison.

Advisors

  • Rex O’Neal, J.D.– Sage Law
    Corporate Attorney
    Unconfirmed
    Mellisa Clary, CPA; Kruger & Clary
    Accountant
    Unconfirmed
    Barry Swanson, J.D. - Swanson & Bratschun
    IP Attorney
    Unconfirmed

Previous Investors

  • Founders
    Unconfirmed
    Non-Dilutive (SBIR and Others)
    Unconfirmed
    CID4
    Unconfirmed
  • CSU Research Foundation
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free